low grade lymphoma

Summary

Summary: One of the three major prognostic groupings for non-Hodgkin lymphomas as proposed in the Working Formulation of the Non-Hodgkin's Lymphoma Pathologic Classification Project sponsored by the National Cancer Institute (1981). Lymphomas falling within this group have a relatively favorable survival potential.

Top Publications

  1. ncbi High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG)
    Rudolf Weide
    Praxisklinik for Hematology and Oncology, Koblenz, Germany
    Leuk Lymphoma 48:1299-306. 2007
  2. ncbi Eleven-year experience of low grade lymphoma in Korea (based on REAL classification)
    Jee Sook Hahn
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Yonsei Med J 44:757-70. 2003
  3. ncbi Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients
    Shing Y Ma
    Department of Medicine, Queen Mary Hospital, Hong Kong, China
    Br J Haematol 124:754-61. 2004
  4. ncbi Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives
    Mathias J Rummel
    Department of Hämatologie Onkologie, Medizinische Universitatsklinik, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Semin Oncol 29:27-32. 2002
  5. ncbi Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model
    A Hollender
    Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo, Norway
    Ann Oncol 13:1099-107. 2002
  6. ncbi Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL)
    E A Jones
    Institute for Cancer Studies, University of Sheffield Medical School, UK
    Leuk Lymphoma 43:1313-21. 2002
  7. ncbi A canine cancer-gene microarray for CGH analysis of tumors
    R Thomas
    Oncology Research Group, Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, UK
    Cytogenet Genome Res 102:254-60. 2003
  8. ncbi Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma
    Roberto Rodriguez
    Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California 91001, USA
    Biol Blood Marrow Transplant 12:1326-34. 2006
  9. ncbi An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphoma
    Nicholas Di Bella
    US Oncology Research, Inc, Houston, Texas, USA
    Cancer 103:978-84. 2005
  10. ncbi Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients
    Lajos Gergely
    Third Department of Internal Medicine, Institute of Internal Medicine, Medical and Health Science Center, University of Debrecen, PO Box 3, H 4004 Debrecen, Hungary
    Eur J Haematol 72:336-41. 2004

Detail Information

Publications203 found, 100 shown here

  1. ncbi High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG)
    Rudolf Weide
    Praxisklinik for Hematology and Oncology, Koblenz, Germany
    Leuk Lymphoma 48:1299-306. 2007
    ..BMR is a very effective new outpatient immuno-chemotherapy with low toxicity for patients with relapsed/refractory FL, MCL and other indolent lymphomas...
  2. ncbi Eleven-year experience of low grade lymphoma in Korea (based on REAL classification)
    Jee Sook Hahn
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Yonsei Med J 44:757-70. 2003
    ..It is considered an indolent disease, but patients with low grade lymphoma can almost never be cured with conventional treatment...
  3. ncbi Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients
    Shing Y Ma
    Department of Medicine, Queen Mary Hospital, Hong Kong, China
    Br J Haematol 124:754-61. 2004
    ..FND is an active regimen for the treatment of indolent B- and T-cell malignancies in Chinese patients, with results comparable with Western patients with similar indolent lymphomas...
  4. ncbi Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives
    Mathias J Rummel
    Department of Hämatologie Onkologie, Medizinische Universitatsklinik, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Semin Oncol 29:27-32. 2002
    ..Optimal treatment regimens with bendamustine in the treatment of low-grade NHL are yet to be defined, but results obtained to date indicate that further studies are warranted...
  5. ncbi Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model
    A Hollender
    Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo, Norway
    Ann Oncol 13:1099-107. 2002
    ..To determine the incidence and risk factors for central nervous system (CNS) relapse in patients with non-Hodgkin's lymphoma (NHL)...
  6. ncbi Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL)
    E A Jones
    Institute for Cancer Studies, University of Sheffield Medical School, UK
    Leuk Lymphoma 43:1313-21. 2002
    ..006) or proliferation (P < 0.0001), which has also been reported in leukemic models. This has important implications for the success of IL-4 as a treatment for low and high grade tumors...
  7. ncbi A canine cancer-gene microarray for CGH analysis of tumors
    R Thomas
    Oncology Research Group, Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, UK
    Cytogenet Genome Res 102:254-60. 2003
    ..We outline the principles of canine microarray development, and present data obtained from microarray analysis of three canine lymphoma cases previously characterized using conventional cytogenetic techniques...
  8. ncbi Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma
    Roberto Rodriguez
    Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, California 91001, USA
    Biol Blood Marrow Transplant 12:1326-34. 2006
    ....
  9. ncbi An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphoma
    Nicholas Di Bella
    US Oncology Research, Inc, Houston, Texas, USA
    Cancer 103:978-84. 2005
    ..In the current study, mitoxantrone (M) was added to P + R to evaluate the toxicity and efficacy of this three-drug combination (PMR)...
  10. ncbi Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients
    Lajos Gergely
    Third Department of Internal Medicine, Institute of Internal Medicine, Medical and Health Science Center, University of Debrecen, PO Box 3, H 4004 Debrecen, Hungary
    Eur J Haematol 72:336-41. 2004
    ..We measured the intracellular cytokine responses in lymphoma patients' lymphocytes, to characterize the polarization changes in their immune system...
  11. ncbi Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma
    M S Czuczman
    Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    J Clin Oncol 23:694-704. 2005
    ..To evaluate the safety and efficacy of fludarabine plus rituximab in treatment-naive or relapsed patients with low-grade and/or follicular non-Hodgkin's lymphoma...
  12. ncbi In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation
    F Lanza
    Section of Hematology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Italy
    Bone Marrow Transplant 32:1165-73. 2003
    ..044). These in vitro data show that CFU-En numbers increase following standard-dose chemotherapy, thus providing a rationale for further investigating the effects of different cytostatic drugs on BM endothelial cells growth and function...
  13. ncbi Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation
    C M P W Mandigers
    Department of Hematology, University Medical Center Nijmegen, The Netherlands
    Bone Marrow Transplant 32:1159-63. 2003
    ..In three cases, clinical responses to DLI could be substantiated by molecular or immunophenotypic analysis of lymphoma cells. We conclude that DLI is effective for treatment of indolent lymphoma relapsing after SCT...
  14. ncbi Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations
    Marco Picardi
    Divisione di Ematologia, II University, Naples, Italy
    Haematologica 88:1296-303. 2003
    ..Chemotherapy can cause hepatitis flare-up through viral reactivation in patients who have had contact with hepatitis viruses. Few data are available on the genotype of the reactivated viruses...
  15. ncbi External beam radiation therapy in the treatment of patients with extranodal stage IA non-Hodgkin's lymphoma
    Jonathan H Briggs
    Department of Radiation Oncology, University of Arizona Cancer Center, 1501 North Campbell Avenue, Tucson, AZ 85724, U S A
    Am J Clin Oncol 25:34-7. 2002
    ..External beam radiation therapy is a highly effective treatment for stage IA NHL found in extranodal sites...
  16. ncbi Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma
    Giovanni Martinelli
    European Institute of Oncology, Milan, Italy
    Br J Haematol 123:271-7. 2003
    ..Based on our preliminary data, the combination of chlorambucil with rituximab seemed to be well tolerated and active. Its definitive role in the treatment of low-grade NHL should be further evaluated in randomized trials...
  17. ncbi Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement
    Jodi V Mones
    Center for Lymphoma and Myeloma, Division of Hematology Oncology, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY 10021, USA
    Leuk Lymphoma 48:342-8. 2007
    ..Two patients had objective responses of 1 and 42.4+ months, respectively. RIT with attenuated dose iodine 131 tositumomab for patients with >25% BMI has acceptable toxicity and can result in lymphoma responses...
  18. ncbi A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma
    Anita Gustavsson
    Department of Oncology, University Hospital, Lund, Sweden
    Acta Oncol 42:605-19. 2003
    ..One randomized clinical trial is published, showing superior therapy results with radiolabelled antibody compared with the corresponding unlabelled antibody...
  19. ncbi The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma
    S Galimberti
    Department of Oncology, Transplant and Advances in Medicine Section of Hematology, University of Pisa, Italy
    Bone Marrow Transplant 29:581-7. 2002
    ..Thus, after high-dose chemotherapy, close molecular monitoring of MRD using qualitative PCR techniques seems to represent a reliable prognostic indicator...
  20. ncbi Rituximab plus chemotherapy in follicular and mantle cell lymphomas
    Wolfgang Hiddemann
    University of Munich, Germany
    Semin Oncol 30:16-20. 2003
    ..A trend towards longer overall and disease-free survival for rituximab plus FCM has been observed, but longer follow-up is required...
  21. ncbi High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality
    Punit D Wadhwa
    Department of Medicine, Comprehensive Cancer Center of the University Hospitals of Cleveland Case Western Reserve University, Cleveland, Ohio 44106, USA
    Biol Blood Marrow Transplant 11:13-22. 2005
    ..BEP with or without IFR is a highly effective and well-tolerated regimen in the relapsed/refractory lymphoma setting. It has low morbidity and transplant-related mortality and a low incidence (3%) of posttransplantation malignancy...
  22. ncbi Primary pulmonary lymphoma
    J Cadranel
    Dept of Pneumology and Respiratory Intensive Care, Tenon Hospital, Paris, France
    Eur Respir J 20:750-62. 2002
    ..The prognosis is extremely variable, with some authors reporting complete remission with steroids and cyclophosphamide and others reporting failure of combination chemotherapy...
  23. ncbi Rituximab in combination with CHOP or fludarabine in low-grade lymphoma
    Myron S Czuczman
    Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Semin Oncol 29:36-40. 2002
    ..One approach to the development of innovative strategies for treatment of NHL has been the generation of monoclonal antibodies to specific B-cell antigens expressed on NHL cells...
  24. ncbi Treatment of follicular non-Hodgkin's lymphoma
    David G Maloney
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave, North Seattle, WA 98104, USA
    Curr Hematol Rep 4:39-45. 2005
    ..These new treatment options make the management of newly diagnosed patients both exciting and a challenge...
  25. ncbi Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma
    Gloria J Morris
    Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
    Haematologica 89:1484-91. 2004
    ..We designed a phase II trial of alternating fludarabine and IFNalpha2a to determine response rate, time to progression and toxicity of this regimen in patients with advanced stage low-grade NHL or mantle cell lymphoma...
  26. ncbi Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies
    Constantine S Tam
    Hematology Service, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    Cancer 100:2181-9. 2004
    ..In the current study, the authors analyzed their experience with an attenuated dose regimen to determine whether equivalent efficacy could be achieved with reduced toxicity...
  27. ncbi Radioimmunotherapy of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
    Robert O Dillman
    Clinical and Laboratory Cancer Research, Hoag Cancer Center, Hoag Hospital, Newport Beach, CA 92658, USA
    Curr Hematol Rep 2:30-7. 2003
    ..The product became available for commercial use in April, 2002. Clinical trials will determine how radioimmunotherapy will be integrated into the treatment of lymphoma...
  28. ncbi The radioisotope contributes significantly to the activity of radioimmunotherapy
    Thomas A Davis
    Stanford University, Stanford, California, USA
    Clin Cancer Res 10:7792-8. 2004
    ....
  29. ncbi Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors
    Jérôme Meunier
    Department of Clinical Hematology, Institut Curie, France
    Hematol Oncol 22:143-58. 2004
    ..In conclusion, with a median follow-up of 7.5 years, our large cohort of patients represents one of the largest published series on primary ophthalmologic and intraocular malignant lymphoma...
  30. ncbi Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up
    Myron S Czuczman
    Roswell Park Cancer Institute, Buffalo, NY, USA
    J Clin Oncol 22:4711-6. 2004
    ..Revised response rates based on International Workshop Response Criteria are also provided...
  31. ncbi Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma
    L Hendry
    Academic Department of Haematology and Cytogenetics, The Royal Marsden NHS Trust, Fulham Road, London SW3 6JJ, UK
    Leuk Lymphoma 45:945-50. 2004
    ..The role of FCM as first line therapy deserves study as well as its combination with the monoclonal antibody Rituximab...
  32. ncbi [Radioimmunotherapy for non-Hodgkin lymphoma: historical development and current status]
    C Emmanouilides
    Division Haematology Oncology, UCLA, Los Angeles, USA
    Rev Esp Med Nucl 25:42-54. 2006
    ..Radioimmunotherapy has been shown to be an effective and clinically relevant complementary therapeutic approach for patients with lymphoma, bringing the Nuclear Medicine into lymphoma therapeutics...
  33. ncbi Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab
    Robert O Dillman
    Hoag Cancer Center, Hoag Hospital, Newport Beach, CA, USA
    Semin Oncol 30:434-47. 2003
    ..Combinations of rituximab with other monoclonal antibodies are currently being tested...
  34. ncbi Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma
    Barbara Pro
    Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Leuk Lymphoma 47:1818-21. 2006
    ..The combination of fludarabine and paclitaxel has clinical activity in patients with recurrent low-grade NHL...
  35. ncbi Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome
    Maurilio Ponzoni
    Department of Pathology, San Raffaele H Scientific Institute, Milan, Italy
    Int J Cancer 106:288-91. 2003
    ..Accordingly, patients with CD10(+) gastric large B-cell lymphomas may be at reduced risk and eligible for clinical trials evaluating more conservative therapeutic options...
  36. ncbi Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
    Stephen P Robinson
    Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation, London, United Kingdom
    Blood 100:4310-6. 2002
    ..A longer period of follow-up is required to determine the benefit of DLI and the graft-versus-lymphoma effect...
  37. ncbi [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group]
    R Forstpointner
    Medizinische Klinik und Poliklinik III, Grosshadern, Klinikum der Universitat Munchen, Germany
    Dtsch Med Wochenschr 127:2253-8. 2002
    ..Further on, phase-II-studies indicate that its addition to chemotherapy may improve the response rate substantially. However, so far, prospective randomized studies have not been available...
  38. ncbi Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis
    Herve Ghesquieres
    Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d Hematologie, France
    J Clin Oncol 24:5234-41. 2006
    ..The characteristics and prognosis of these particular DLBCL are not well known...
  39. ncbi Cure of incurable lymphoma
    Gerald L DeNardo
    Radiodiagnosis and Therapy, Division of Hematology Oncology, University of California Davis Medical Center, Sacramento, CA, USA
    Int J Radiat Oncol Biol Phys 66:S46-56. 2006
    ..Predictable improvements using better drugs, strategies, and combinations with other drugs seem certain to make RIT integral to the management of patients with NHL, and likely lead to cure of currently incurable NHL...
  40. ncbi Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma
    Apostolia M Tsimberidou
    Department of Lymphoma and Myeloma, University of Texas, M D Anderson Cancer Center, Houston 77030, USA
    Blood 100:4351-7. 2002
    ..In conclusion, both regimens were associated with high rates of response and survival. ATT was associated with substantially longer FFS, but it was more toxic than FND...
  41. ncbi Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma
    Mathias J Rummel
    Med Klinik II, Johann Wolfgang Goethe Universitätsklinik, Frankfurt Main, Germany
    J Clin Oncol 23:3383-9. 2005
    ....
  42. ncbi Clinicopathologic and immunohistochemical study of surgically treated primary gastric MALT lymphoma
    Luigi Insabato
    Department of Anatomic Pathology, School of Medicine, Federico II University of Naples, Naples, Italy
    J Surg Oncol 83:106-11. 2003
    ..Immunohistochemical expression of p53, bcl-2, and Ki67 and Helicobacter pylori (Hp) infection was evaluated, along with a correlation with clinical outcome...
  43. ncbi Lymphoma of the ocular adnexa: A study of 353 cases
    Judith A Ferry
    James Homer Wright Pathology Laboratories of the Massachusetts General Hospital, Massachusetts General Hospital, Boston, MA 02114, USA
    Am J Surg Pathol 31:170-84. 2007
    ..High-grade B-cell lymphomas only occasionally involve the ocular adnexa, and T-cell lymphoma, NK-cell lymphoma, and Hodgkin lymphoma are only rarely encountered in this site...
  44. ncbi Fluorescence in situ hybridization detection of chromosome IGH/BCL2 translocations from paraffin-embedded tissue: evaluation in follicular lymphoma
    Yuko Hirose
    Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan
    Int J Hematol 78:154-9. 2003
    ..Performing FISH on paraffin sections also is useful because we can identify cells with genetic abnormalities in the tumor and make a retrospective cytogenetic diagnosis even with old paraffin-embedded specimens...
  45. ncbi Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma
    D Przepiorka
    Department of Blood and Marrow Transplantation, University of Texas, M D Anderson Cancer Center, Houston, USA
    Ann Oncol 10:527-32. 1999
    ....
  46. ncbi [Primary digestive tract lymphoma in central region of Tunisia: anatomoclinical study and therapeutic results about 153 cases]
    A Landolsi
    Service de médecine carcinologique, CHU Farhat Hached, Sousse, Tunisie
    Bull Cancer 97:435-43. 2010
    ..Recent progress in chemotherapy has allowed good therapeutic results with a conservative approach. Surgery may be performed in case of emergency or for residual lesions after medical treatment...
  47. ncbi Gastric non-Hodgkin's lymphoma: analysis of 252 patients from a multicenter study
    L Salvagno
    Divisione di Oncologia Medica, Centro Oncologico Regionale, Padua
    Tumori 85:113-21. 1999
    ..According to the Working Formulation, 98 patients had low grade lymphoma, 59 intermediate grade (D to F), 81 G or high grade and 14 were not classified...
  48. ncbi Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma
    M S Kaminski
    Department of Internal Medicine, University of Michigan, Ann Arbor 48109 0724, USA
    J Clin Oncol 14:1974-81. 1996
    ....
  49. pmc Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group
    D Wright
    University Department of Pathology, Southampton General Hospital
    J Clin Pathol 50:128-34. 1997
    ..To review the presenting clinical features and the histology of cases of non-Hodgkin lymphoma (NHL) entered into the United Kingdom Children's Cancer Study Group NHL Trial...
  50. pmc Hepatitis C virus-induced cryoglobulinemia
    Edgar D Charles
    Center for the Study of Hepatitis C, The Rockefeller University, New York, New York 10065, USA
    Kidney Int 76:818-24. 2009
    ..It is unclear how B cells become dysregulated during the course of chronic HCV infection, and continued patient-centered research is necessary to elucidate the pathogenesis of HCV-related B-cell dysregulation...
  51. ncbi Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders
    Gerassimos A Pangalis
    First Department of Internal Medicine and Department of Hematology, National and Kapodistrian University of Athens, Laikon General Hospital, 16 Sevastoupoleos Street, Athens 11526, Greece
    Clin Lymphoma 5:235-40. 2005
    ..Research in this field should continue to further clarify the disease entities that overlap with WM. New technology such as gene-expression profile techniques may contribute to this purpose...
  52. ncbi Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States)
    Ikuko Kato
    Department of Environmental Medicine, New York University of School of Medicine, New York, NY, USA
    Cancer Causes Control 16:1215-24. 2005
    ..The authors assessed whether home and occupational exposure to organic solvents is associated with risk of NHL in women...
  53. ncbi Comparative analysis of the Helicobacter pylori status in patients with gastric MALT-type lymphoma and their respective spouses
    W Fischbach
    Medizinische Klinik II, Klinikum Aschaffenburg, Akademisches Lehrkrankenhaus, Universitat Wurzburg
    Z Gastroenterol 38:627-30. 2000
    ..In case of localized low grade lymphoma successfully treated by Helicobacter pylori eradication reinfection by the bacterium may involve the risk of ..
  54. ncbi Cladribine treatment in two-hour intravenous infusion for previously-treated low grade B-cell lymphoma: a pilot study
    Yasushi Takamatsu
    Division of Medical Oncology, Hematology and Infectious Disease, Department of Medicine, Fukuoka University Hospital, Jonan ku, Fukuoka, Japan
    J Clin Exp Hematop 49:69-75. 2009
    ..Cladribine can be administered in 2-hour infusion in an outpatient clinic and is therefore quite convenient for patients...
  55. ncbi Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma
    M Lazzarino
    Institute of Hematology, University of Pavia, Italy
    Ann Oncol 10:59-64. 1999
    ..Our aim was to define the therapeutic efficacy and toxicity of a combination of fludarabine, cyclophosphamide and dexamethasone (FluCyD) in patients with advanced low-grade lymphoma...
  56. ncbi Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose
    Sith Phongkitkarun
    Department of Radiology, Faculty of Medicine, Ramathibodi Hospital, Rama VI Road, Rajchathewi, Bangkok 10400, Thailand
    World J Gastroenterol 11:7284-9. 2005
    ....
  57. ncbi Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)
    George Papaxoinis
    Second Department of Internal Medicine, Athens University, University General Hospital Attikon, Haidari, Greece
    Leuk Lymphoma 47:2140-6. 2006
    ..0001). The International Prognostic Index (IPI) for patients with aggressive lymphomas was prognostic only for DFS (79% for low-risk patients [IPI score 0 - 1] vs 49% for higher risk groups [IPI score >1] at 3-year, P = 0.0131)...
  58. ncbi A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma
    Stephan Hellmig
    Department of General Internal Medicine, University Clinics of Schleswig Holstein, Campus Kiel, Germany
    Am J Gastroenterol 100:2644-9. 2005
    ..We investigated four functional promotor polymorphisms in the TNF-alpha gene for association with the development of primary gastric B-cell lymphoma...
  59. ncbi Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
    A Boland
    Liverpool Reviews and Implementation Group, Sherrington Buildings, University of Liverpool, Liverpool, UK
    Health Technol Assess 13:41-8. 2009
    ..randomised controlled trials [European Organisation for Research and Treatment of Cancer (EORTC) and German Low Grade Lymphoma Study Group - Fludarabine, Cyclophosphamide and Mitoxantrone and (GLSG-FCM)] comparing the clinical effects ..
  60. ncbi Morphometric analysis of AgNORs in the lymph node lesions
    B Arora
    Department of Pathology, P G I M S, Rohtak, India
    Adv Clin Path 6:95-9. 2002
    ..17 +/- 0.255) when compared with low grade lymphoma (4.78 +/- 0.41) and reactive lymph nodes (2.45 +/- 0.486)...
  61. ncbi The spleen as a diagnostic specimen: a review of 10 years' experience at two tertiary care institutions
    M D Kraus
    Department of Pathology, Barnes Jewish Hospital, St Louis, Missouri, USA
    Cancer 91:2001-9. 2001
    ..The current study correlates clinical intent with preoperative clinical and radiologic studies and histologic findings in an assessment of the diagnostic yield of splenectomy...
  62. ncbi Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification
    Masatoshi Hasegawa
    Department of Radiology and Radiation Oncology, Gunma University School of Medicine, Maebashi, Japan
    Int J Radiat Oncol Biol Phys 57:172-6. 2003
    ..To analyze the results of radiotherapy (RT) for malignant lymphoma of the orbit and to evaluate them compared with the World Health Organization (WHO) classification published in 2001...
  63. ncbi Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage
    E Zuckerman
    Liver Unit, the Department of Internal Medicine A, Bnai Zion Medical Center, 47 Golomb St, PO Box 4940, Haifa 31048, Israel
    Blood Rev 16:119-25. 2002
    ..Whether to treat low-grade HCV-related lymphomas with anti-viral therapy is still debatable, but encouraging data emerge from recent studies...
  64. ncbi Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group
    H S Hochster
    New York University, New York, NY, USA
    J Clin Oncol 18:987-94. 2000
    ..To determine the toxicity and recommended phase II doses of the combination of fludarabine plus cyclophosphamide in chemotherapy-naive patients with low-grade lymphoma...
  65. ncbi Feline alimentary lymphoma: demystifying the enigma
    Heather M Wilson
    Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Texas A and M University, College Station, TX 77843, USA
    Top Companion Anim Med 23:177-84. 2008
    ..The purpose of this article is to tackle the challenges of this allusive disease with a step-by-step approach to diagnosis, staging, and therapy...
  66. ncbi Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen
    Richard J Klasa
    Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada
    J Clin Oncol 20:4649-54. 2002
    ..To compare in a phase III study the safety and efficacy of fludarabine to that of cyclophosphamide, vincristine, and prednisone (CVP) in recurrent, low-grade, non-Hodgkin's lymphoma after previous response to systemic treatment...
  67. ncbi Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Gro
    Georg Lenz
    Department of Internal Medicine III, Ludwig Maximilians University, University Hospital Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
    J Clin Oncol 22:4926-33. 2004
    ..To assess this risk more precisely, the German Low Grade Lymphoma Study Group investigated the incidence of t-MDS/t-AML after ASCT on the basis of a randomized comparison of ..
  68. ncbi Cat scratch disease mimicking Richter's Syndrome in a patient with chronic lymphocytic leukemia
    Mohammad Razaq
    Department of Hematology, Coney Island Hospital, Brooklyn, NY 11235, USA
    Leuk Lymphoma 46:443-5. 2005
    ..It occurs as a result of transformation of chronic lymphocytic leukemia (CLL) or low grade lymphoma into highly aggressive lymphoma...
  69. ncbi Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience
    H Akbulut
    Department of Medical Oncology, Ibn i Sina Hospital, Ankara University School of Medicine, Sihhiye Ankara, Turkey
    Cancer 80:8-14. 1997
    ..Currently, there is no agreement regarding optimal treatment strategies for immunoproliferative small intestinal disease (IPSID). In this article, the authors report the treatment outcomes of a group of 23 Turkish patients with IPSID...
  70. ncbi Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas
    Semra Paydas
    Department of Oncology, Cukurova University, Faculty of Medicine, Adana, Turkey
    Leuk Res 32:1424-30. 2008
    ..The viral latent protein LMP1, may play a role by inducing expression of angiogenic factors In this study EBV-LMP1 and VEGF-A expressions have been studied in cases with NHL and prognostic significance of these has been evaluated...
  71. ncbi Bilateral conjunctival mucosa-associated lymphoid tissue lymphoma misdiagnosed as allergic conjunctivitis
    D H Lee
    Department of Ophthalmology and Anatomic Pathology, Ilsan Paik Hospital, Ilsan, Korea
    Cornea 20:427-9. 2001
    ..This report aimed to discuss two nearly identical cases of primary conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma mimicking allergic conjunctivitis...
  72. ncbi [Prevalence of hepatitis B and C virus, HTLV-1 and HIV in type B lymphoproliferative syndromes in Gabon]
    J L Perret
    institut de médecine tropicale, service de santé des armées, Le Pharo, Marseille, France
    Bull Soc Pathol Exot 96:275-8. 2003
    ..HIV were compared in 40 patients (21 men, 19 women; 17 < age < 75 years) with newly diagnosed B-LPD (low grade lymphoma = 6, intermediate grade = 21, high grade = 8: chronic lymphocytic leukaemia = 5) and 160 age and sex-matched ..
  73. ncbi Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide
    Meletios A Dimopoulos
    Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
    Leuk Lymphoma 44:993-6. 2003
    ..We conclude that the FC combination appears to be active in patients with WM most of whom were resistant to treatment and had poor prognostic factors. The addition of rituximab to FC requires further investigation...
  74. ncbi Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group
    Wolfram Klapper
    Department of Pathology, Hematopathology Section and Lymph Node Registry, Kiel, Germany
    J Clin Oncol 25:3330-6. 2007
    ..Several histopathologic biomarkers for risk stratification have been suggested, but most markers have not been validated in patients treated in prospective trials...
  75. ncbi Gastrointestinal follicular lymphoma: review of the literature
    Shuji Yamamoto
    Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    J Gastroenterol 45:370-88. 2010
    ..Ongoing research on biomarkers to guide individualized GI-FL therapy may provide invaluable information that will lead to the establishment of a standard therapeutic regimen...
  76. ncbi Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphoma
    Henry K Wong
    Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
    J Invest Dermatol 126:212-9. 2006
    ..These findings reveal an abnormal regulation of CTLA-4 expression in MF and show that PBMCs from patients with MF have properties that are divergent from those of normal T cells...
  77. ncbi Rituximab as first-line monotherapy in low-grade follicular lymphoma with a low tumor burden
    P Solal-Celigny
    Centre Jean Bernard, Le Mans, France
    Anticancer Drugs 12:S11-4. 2001
    ..Rituximab monotherapy is therefore an effective and well-tolerated treatment for patients with low-grade lymphoma and a low tumor burden...
  78. ncbi Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: r
    Wolfgang Hiddemann
    Department of Internal Medicine III, University of Munich, Grosshadern Marchioninistr 15, 81377 Munchen, Germany
    Blood 106:3725-32. 2005
    ..Hence, adding rituximab to CHOP significantly improves the outcome for patients with previously untreated advanced-stage FL and does not induce major adverse effects...
  79. ncbi [Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases]
    Hui Qiang Huang
    Department of Medical Oncology, Cancer Center, Sun Yat Sen University, Guangzhou, Guangdong, 510060, PR China
    Ai Zheng 23:448-51. 2004
    ..Significantly higher response rate can be yielded by combined regimen such as FN, FMD, and FC, etc. The purpose of this study was to investigate the efficacy and toxicity of fludarabine-based regimen for patients with lymphoma in China...
  80. ncbi 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer
    Orazio Schillaci
    Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University Hospital Tor Vergata, Rome, Italy
    Nucl Med Commun 31:39-45. 2010
    ..The aim of this study was to describe the whole-body physiologic distribution of 18F-choline and to discuss some abnormal sites of uptake not related to PC we observed...
  81. ncbi Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study
    N A Willich
    Department of Radiotherapy, University of Munster, Munster, Germany
    Int J Radiat Oncol Biol Phys 46:895-901. 2000
    ..Aim of study was the further standardization of operative and conservative treatment modalities...
  82. ncbi Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study
    Andrew M Scott
    Centre for PET, Austin Hospital, Studley Rd, Heidelberg, Melbourne, Victoria 3084, Australia
    Eur J Nucl Med Mol Imaging 36:347-53. 2009
    ..Positron emission tomography (PET) was evaluated in low-grade non-Hodgkin lymphoma (NHL) to determine its impact on staging and management and to compare PET and gallium scans...
  83. ncbi Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995-2005)
    Michael A Kiselow
    Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA
    J Am Vet Med Assoc 232:405-10. 2008
    ..To evaluate factors associated with response to treatment, remission duration, and survival in cats with low-grade lymphoma affecting various organ systems...
  84. ncbi Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
    I F Khouri
    Department of Hematology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    J Clin Oncol 16:2817-24. 1998
    ....
  85. ncbi Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group
    W Hiddemann
    Department of Hematology and Oncology, University of Gottingen, Germany
    J Clin Oncol 16:1922-30. 1998
    ..To compare mantle-cell lymphomas (MCLs) and follicle-center lymphomas (FCLs) for their features of clinical presentation, response to chemotherapy, and prognosis on the basis of a prospective randomized clinical trial...
  86. ncbi High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma
    P J Bierman
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198 3330, USA
    J Clin Oncol 15:445-50. 1997
    ..This study evaluated the results of high-dose therapy followed by autologous bone marrow or peripheral-blood stem-cell transplantation for patients with follicular low-grade non-Hodgkin's lymphoma...
  87. ncbi Treatment of conjunctival lymphomas by beta-ray brachytherapy using a strontium-90-yttrium-90 applicator
    C A Regueiro
    Department of Radiation Oncology, Hospital Universitario Clinica Puerta de Hierro, San Martin de Porres, Madrid, Spain
    Clin Oncol (R Coll Radiol) 14:459-63. 2002
    ....
  88. ncbi [Autologous transplantation of hematopoietic stem cells--therapeutic spectrum and future developments]
    W Hinterberger
    2 Medizinische Abteilung des Donauspitals im SMZ Ost der Stadt Wien, Langobardenstrasse 122, A 1220 Wien
    Acta Med Austriaca Suppl 52:1-7. 2000
    ..ASTx are routinely performed in aggressive lymphoma. Indications for ASTx in intermediate and low grade lymphoma await results of clinical trials...
  89. ncbi Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement
    Chantana Polprasert
    Division of Hematology, Department of Medicine, Srinakarinwirot University, Bangkok, Thailand
    J Med Assoc Thai 92:S65-8. 2009
    Lymphoplasmacytic lymphoma (LPL) is a low grade lymphoma. Most cases are Waldenstorm macroglobulinemia which has IgM hypergammaglobulinemia. Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia is less than 5%...
  90. ncbi The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vinc
    Christian Buske
    Department of Internal Medicine III, University of Munich, Grosshadern, Marchioninistr 15, 81377 Munchen, Germany
    Blood 108:1504-8. 2006
    ..patients with advanced-stage FL treated front-line with rituximab/CHOP in a prospective trial of the German Low Grade Lymphoma Study Group...
  91. ncbi Mantle cell lymphoma: established therapeutic options and future directions
    G Lenz
    Department of Internal Medicine III, Grosshadern Hospital, Ludwig Maximilians University, 81377 Munich, Germany
    Ann Hematol 83:71-7. 2004
    ..Recently, two prospective randomized studies of the German Low Grade Lymphoma Study Group (GLSG) clearly confirmed the superiority of a combined immunochemotherapy...
  92. ncbi Primary low-grade and high-grade gastric MALT-lymphoma presentation
    Angelo Zullo
    Gastroenterology and Digestive Endoscopy, Haematology, Nuovo Regina Margherita Hospital, La Sapienza University, Rome, Italy
    J Clin Gastroenterol 44:340-4. 2010
    ..To assess the clinical and endoscopic presentation of primary gastric lymphoma...
  93. ncbi Torsion of quadrate and right middle liver lobes and gallbladder in a German Shepherd dog
    F Massari
    Clinica Veterinaria Nerviano, Nerviano MI, Italy
    Aust Vet J 90:44-7. 2012
    ..Abdominal ultrasonography revealed abundant abdominal effusion and a right liver mass in continuity with a cystic structure. The dog had undergone splenectomy for a low-grade lymphoma 1 year prior...
  94. ncbi Treatment options for primary splenic low-grade non-Hodgkin's lymphomas
    V Gh Musteata
    Department of Hematology and Oncology, State Medical and Pharmaceutical University N Testemitanu, Chisinau, Republic of Moldova
    Clin Lab Haematol 26:397-401. 2004
    ....
  95. ncbi Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder
    Karen L Grogg
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg Pathol 37:406-12. 2013
    ..The association of nodular pulmonary amyloidoma with autoimmune disease and lymphoma indicate the majority of these lesions relate to an underlying lymphoplasmacytic neoplasm in the spectrum of MALT lymphoma...
  96. ncbi Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Group
    Thomas E Witzig
    Department of Internal Medicine, Division of Hematology, Mayo Clinic 200 First St SW, Rochester, MN 55905, USA
    J Clin Oncol 23:1103-8. 2005
    ..The goals of this study were to assess the overall response rate (ORR) to rituximab in this patient population and to determine the time-to-progression (TTP) and time-to-subsequent-chemotherapy (TTSC)...
  97. ncbi Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients
    Pei Lin
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Am J Clin Pathol 123:200-5. 2005
    ..Thus, serum IgM paraprotein level is not a reliable discriminator in differential diagnosis...
  98. ncbi Low-grade non-hodgkin lymphomas
    Richard W Tsang
    Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
    Semin Radiat Oncol 17:198-205. 2007
    ..Patients with stage III and IV low-grade lymphoma and local symptoms are often successfully palliated with a low dose regimen of 2 x 2 Gy (total dose 4 Gy)...
  99. ncbi cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy
    Guido Valente
    Laboratorio di Anatomia Patologica, Universita del Piemonte Orientale A Avogadro, Novara, Italy
    Br J Haematol 132:560-70. 2006
    ..The present findings strongly indicate that cFLIP is a reliable predictor of tumour progression and clinical prognosis in NHLs of low grade of malignancy...
  100. ncbi Radiotherapy for low-grade gastric marginal zone lymphoma: a retrospective study
    M L Lin
    Department of Radiation Oncology, Peter MacCallum Cancer Centre, Victoria, Melbourne, Australia
    Intern Med J 37:172-80. 2007
    ..We evaluated the efficacy and toxicity of radiotherapy (RT) in patients with low-grade gastric marginal zone lymphoma...
  101. ncbi Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients
    Catia Igreja
    Angiogenesis Laboratory, Centro Investigação em Patobiologia Molecular, Instituto Portugues de Oncologia Francisco Gentil, Centro Regional de Oncologia de Lisboa, Lisboa, Portugal
    Haematologica 92:469-77. 2007
    ..However, the involvement and relevance of EPC in human cancers remain poorly studied. We, therefore, investigated the presence, differentiation potential and molecular characteristics of EPC in lymphoma patients...

Research Grants9

  1. RADIOIMMUNOTHERAPY OF LYMPHOMA
    Mark Kaminski; Fiscal Year: 2000
    ..These proposed integrated studies should help answer important fundamental questions regarding RIT and help develop this new and promising strategy for the treatment of lymphomas in general. ..
  2. ANTI-CD20 ANTIBODY THERAPY OF NHL-- MECHANISM OF ACTION
    David Maloney; Fiscal Year: 2002
    ..III. Determine the role of the mAb FC region in mediating anti- proliferative effects of anti-CD20 mAbs in xenografts of B cell NHL lines in NOD/SCID mice. ..
  3. Genetic Susceptibility to Infection Related Cancer
    Ikuko Kato; Fiscal Year: 2005
    ..Secondary aims include to examine histopathological correlates of these polymorphisms and to determine whether selected environmental factors modify the above associations. ..
  4. Luminal Lipid Exposure, Genetics and Colon Cancer Risk
    Ikuko Kato; Fiscal Year: 2006
    ..In addition, accumulated dietary data and biological specimens will serve as an important resource for future research on other nutrient-gene interactions. ..
  5. HIV, Race and Survival in the Highly Active Therapy Era
    Thomas Giordano; Fiscal Year: 2007
    ..unreadable] [unreadable]..
  6. Attitudes and Beliefs and the Steps of HIV Care
    Thomas Giordano; Fiscal Year: 2008
    ..These studies will allow us to identify modifiable factors for improving outcomes, and target the Step of HIV Care where interventions should be focused to maximize impact. ..
  7. Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
    Howard Hochster; Fiscal Year: 2008
    ..unreadable] [unreadable]..
  8. Validation of RNA and DNA Biomarkers of Prognosis in Chronic Lymphocytic Leukemia
    Lynne Abruzzo; Fiscal Year: 2008
    ..We are attempting to devise a new clinical test, based on new discoveries in molecular medicine, to help doctors identify patients who may need aggressive therapy early in their disease course. [unreadable] [unreadable] [unreadable]..